Emilly Schlee Villodre

8PUBLICATIONS
30CO-AUTHORS
Predictive and prognostic markersMolecular targetsComputational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)Cancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 06, 2026
Serum S100A8/S100A9 is associated with increased risk of brain metastasis in patients with inflammatory breast cancer.

Emilly S Villodre, Juhee Song, Xiaoding Hu

|May 13, 2025
Inhibition of MCL-1 and MEK Overcomes MEK Inhibitor Resistance in Triple-Negative and Inflammatory Breast Cancers.

Mohd Mughees, Moises Tacam, Alex W Tan

|Apr 13, 2024
NDRGs in Breast Cancer: A Review and In Silico Analysis.

Emilly S Villodre, Anh P N Nguyen, Bisrat G Debeb

|Feb 15, 2022
SPDL1 Is an Independent Predictor of Patient Outcome in Colorectal Cancer.

Anna Klimaszewska-Wiśniewska, Karolina Buchholz, Justyna Durślewicz

|Aug 27, 2021
Targeting Lipocalin-2 in Inflammatory Breast Cancer Cells with Small Interference RNA and Small Molecule Inhibitors.

Ginette S Santiago-Sánchez, Ricardo Noriega-Rivera, Eliud Hernández-O'Farrill

|Aug 03, 2021
Lipocalin 2 promotes inflammatory breast cancer tumorigenesis and skin invasion.

Emilly S Villodre, Xiaoding Hu, Richard Larson

Pageof 2

Frequent Collaborators

3 joint publications

Naoto T Ueno

3 joint publications

Debu Tripathy

2 joint publications

Bisrat G Debeb

2 joint publications

Wendy A Woodward